2025-12-22 - Analysis Report
Okay, here's a comprehensive analysis of Lam Research Corp (LRCX) based on the data provided:

**0) Introduction**

This report analyzes Lam Research Corp (LRCX) through return comparison with the S&P 500 (VOO), Alpha/Beta analysis, recent stock price movement, technical indicators, news & events, analyst opinions, earnings, and financial information. This will provide a holistic view of the stock's current standing.

**1) Return Rate Comparison**

*   **LRCX:** Lam Research Corp. is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry.
*   **Cumulative Return (LRCX):** 258.61%
*   **Cumulative Return (VOO):** 100.88%
*   **Divergence:**  The cumulative return of LRCX exceeds VOO by 157.7 percentage points. This divergence ranges from a minimum of -15.5 to a maximum of 157.7. Currently, the relative divergence is at 100%, indicating it's at the high end of its historical divergence range.

**Analysis:** LRCX has significantly outperformed the S&P 500. The high relative divergence suggests that this outperformance is currently near its peak compared to its recent history. The magnitude of this difference in performance highlights the strength of LRCX relative to the overall market.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha  | Beta | Cap(B) |
|------------|---------|--------|--------|------|--------|
| 2015-2017  | 84.0%   | 67.8%  | 56.0%  | 0.0  | 23.2   |
| 2016-2018  | 18.0%   | 68.1%  | 3.0%   | 0.1  | 17.2   |
| 2017-2019  | 53.0%   | 82.9%  | 31.0%  | 1.2  | 36.9   |
| 2018-2020  | 66.0%   | 82.9%  | 42.0%  | 1.1  | 59.5   |
| 2019-2021  | 119.0%  | 82.9%  | 73.0%  | 1.0  | 90.7   |
| 2020-2022  | -10.0%  | 79.2%  | -9.0%  | 0.9  | 53.0   |
| 2021-2023  | -13.0%  | 80.4%  | -15.0% | 1.0  | 98.8   |
| 2022-2024  | -52.0%  | 80.4%  | -72.0% | 1.0  | 91.1   |
| 2023-2025  | 170.0%  | 80.4%  | 104.0% | 0.9  | 217.2  |

*   **CAGR:** The Compound Annual Growth Rate varies significantly. Note the recent high growth (170%) compared to previous years.  Some periods showed negative CAGR.
*   **MDD:**  Maximum Drawdown is consistently high (around 80%), indicating significant potential for price declines.
*   **Alpha:** LRCX consistently showed a good Alpha value, which indicates its ability to generate returns above the benchmark.
*   **Beta:** Beta generally hovers around 1, meaning the stock's volatility is similar to the market.
*   **Cap(B):**  Market capitalization has increased substantially over time, reflecting the company's growth.

**Analysis:**  The Alpha/Beta analysis reveals a mixed picture. While LRCX has generally delivered strong alpha (excess return for the risk taken) and grown its market capitalization, it also exhibits high volatility (high MDD). The Beta around 1 suggests market-correlated volatility.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 172.27
*   **Previous Close:** 164.7
*   **Change:** 4.6
*   **5-day SMA:** 163.90
*   **20-day SMA:** 159.63
*   **60-day SMA:** 152.14

**Analysis:**  The stock is trading above its 5-day, 20-day, and 60-day Simple Moving Averages, indicating a current uptrend. The significant price increase from the previous close (change of 4.6) reinforces this bullish sentiment.

**3) Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 62.30 (Neutral, tending towards Overbought)
*   **PPO:** 0.20 (Positive Momentum)
*   **Hybrid Signal:** "cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)" - This suggests a strong buy signal.
*   **Recent (20 days) relative divergence change:** 9.1 (+) - This signifies a short-term increase in divergence.
*   **Expected Return:** 14.2% - Indicates a potentially high excess return compared to the S&P 500 over a long-term investment horizon.

**Analysis:** The MRI suggests a moderate risk level. The RSI indicates the stock is approaching overbought territory. The PPO points to positive momentum. The hybrid signal gives a strong buy indication. The increase in relative divergence change indicates the stock is outperforming in the short term. The expected return is very optimistic.

**4) Recent News & Significant Events**

The recent news headlines are largely positive, driving the stock price upward:

*   **"Why Is Lam Research (LRCX) Stock Soaring Today"**: Implies a significant positive catalyst is driving the price.
*   **"Lam Research (LRCX) Stock After Hours Today (Dec. 19, 2025)":** Suggests news that happened after market hours.
*   **"Lam Research, IBD Stock Of The Day, Hits All-Time High On 2026 Prospects":**  Highlights positive future outlook.
*   **"Why Lam Research (LRCX) Stock Is Up Today"**: Confirms a positive trend with a reason.
*   **"Would You Still Hold Lam Research Stock If It Fell 30%?":** A more cautious article considering potential risks and downside scenarios.
*   **"Lam Research Corporation $LRCX Stock Position Lifted by Voya Investment Management LLC":** Indicates institutional investors are increasing their holdings, which is generally positive.

**Analysis:** The news sentiment is overwhelmingly positive, supporting the recent price increase and positive technical indicators. The all-time high and optimistic outlook for 2026 are strong drivers.

**4-2) Analyst Opinions**

*   **Consensus:**  Buy
*   **Mean Rating:** 1.79 (~Buy)
*   **Number of Opinions:** 30
*   **Target Price (avg/high/low):** 166.13 / 210.00 / 84.00
*   **Recent Rating Changes:** (No changes available)

**Analysis:**  The analyst consensus is a "Buy" with a mean rating indicating a generally positive outlook. The average target price is 166.13, lower than the current price of 172.27, suggesting it may be overvalued currently.  However, the high target price of 210.00 indicates some analysts are highly optimistic.

**5) Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-10-24 | 1.24  | 5.32 B$   |
| 2025-04-25 | 1.04  | 4.72 B$   |
| 2025-01-31 | 0.93  | 4.38 B$   |
| 2024-10-28 | 0.86  | 4.17 B$   |
| 2025-10-24 | 0.86  | 4.17 B$   |

**Analysis:**  EPS and revenue generally increased in the recent quarters, showing continuous growth of the business.

**6) Financial Information**

Revenue and Profitability:

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $5.32B    | 50.43%        |
| 2025-06-30   | $5.17B    | 50.08%        |
| 2025-03-31   | $4.72B    | 49.02%        |
| 2024-12-31   | $4.38B    | 47.37%        |
| 2024-09-30   | $4.17B    | 48.05%        |

Capital and Profitability:

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-09-30   | $10.19B   | 15.39%    |
| 2025-06-30   | $9.86B    | 17.44%    |
| 2025-03-31   | $9.51B    | 13.99%    |
| 2024-12-31   | $8.81B    | 13.52%    |
| 2024-09-30   | $8.47B    | 13.18%    |

**Analysis:** Revenue, equity and ROE have been on a rise, which shows the health and financial stability of the company.

**7) Comprehensive Analysis (Summary)**

Lam Research Corp. (LRCX) is currently experiencing strong positive momentum. It has significantly outperformed the S&P 500, fueled by positive news and analyst sentiment. The technical indicators suggest a potentially overbought condition, but the hybrid signal remains a strong buy. Recent earnings and revenue data show a company in growth mode. However, the high MDD and average analyst price target being lower than the current price suggest potential risks and possible overvaluation.

**Conclusion:**

LRCX appears to be a strong stock, but investors should be aware of the high volatility and potential for a pullback. The company's growth prospects, particularly in the semiconductor industry, appear promising. A cautious approach, considering the potential downside risks, is recommended. It might be wise to consider a partial profit taking due to the recent run-up.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.